CCM Concord Medical Services Holdings Ltd Annual reports only
Services-Offices & Clinics of Doctors of Medicine · NYSE · SEC CIK 1472072 · Reporting currency CNY
Financial factors as of 2018-12-31 (FY2018), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 · CNY | FY20242024-12-31 · USD | FY20232023-12-31 · CNY | FY20222022-12-31 · CNY | FY20212021-12-31 · USD |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 460.51M | $52.60M | 537.40M | 472.08M | $76.21M |
| Cost of revenue | 434.69M | $63.45M | 614.01M | 624.49M | $85.14M |
| Gross profit | 25.82M | -$10.85M | -76.61M | -152.41M | -$8.93M |
| SG&A expense | 212.97M | $55.40M | 330.08M | 311.16M | $54.57M |
| Operating income | -261.49M | -$72.91M | -462.99M | -525.05M | -$71.92M |
| Interest expense | 152.33M | $26.47M | 165.67M | 120.36M | $11.58M |
| Pretax income | -373.36M | -$91.73M | -555.59M | -839.90M | $83.05M |
| Income tax | 6.06M | -$2.40M | -24.57M | -70.91M | -$1.03M |
| Net income | -92.81M | -$42.23M | -297.66M | -489.66M | -$42.59M |
| EBITDA | -157.98M | -$61.29M | -380.86M | -436.36M | -$61.83M |
| EPS (basic) | -0.71 | -0.32 | -2.27 | -3.74 | -0.98 |
| EPS (diluted) | -0.71 | -0.32 | -2.27 | -3.74 | -0.98 |
| Weighted avg. shares (diluted) | 131.05M | 131.05M | 131.05M | 131.05M | 131.05M |
| Banking | |||||
| Loans, net | — | — | — | 294.13M | $26.56M |
| Balance sheet | |||||
| Cash & equivalents | 297.79M | $33.89M | 58.14M | 159.34M | $23.04M |
| Short-term investments | 1,000 | $18.44M | — | — | — |
| Receivables | 44.05M | $7.01M | 73.50M | 130.27M | $20.07M |
| Inventory | 45.97M | $4.58M | 40.35M | 84.83M | $5.98M |
| Current assets | 941.91M | $134.80M | 617.21M | 759.80M | $91.72M |
| PP&E, net | 3.72B | $507.49M | 3.55B | 3.26B | $493.52M |
| Goodwill | 572.22M | $81.83M | 575.43M | 575.43M | $84.36M |
| Intangibles | 255.91M | $40.02M | 323.29M | 353.77M | $103.23M |
| Total assets | 6.55B | $921.51M | 6.05B | 6.00B | $977.62M |
| Current liabilities | 1.95B | $291.17M | 1.95B | 1.12B | $126.25M |
| Short-term debt | 981.06M | $141.48M | 1.04B | 512.58M | $46.97M |
| Long-term debt | 2.47B | $369.03M | 1.99B | 2.47B | $341.87M |
| Total debt | 3.45B | $510.51M | 3.04B | 2.98B | $388.84M |
| Total liabilities | 4.70B | $699.88M | 4.31B | 3.99B | $547.07M |
| Shareholders' equity | -2.10B | -$312.41M | -2.12B | -1.86B | -$215.00M |
| Net debt | 3.15B | $476.62M | 2.98B | 2.82B | $365.80M |
| Cash flow statement | |||||
| Operating cash flow | -201.82M | -$54.49M | -276.47M | -216.69M | -$56.39M |
| Capital expenditure | 56.32M | $20.66M | 113.00M | 222.98M | $43.78M |
| Free cash flow | -258.15M | -$75.15M | -389.47M | -439.67M | -$100.17M |
| Investing cash flow | 53.97M | -$81.30M | -47.68M | -118.79M | -$88.81M |
| Financing cash flow | 197.23M | $157.00M | 257.65M | 383.09M | $100.81M |
| Depreciation & amortization | 103.51M | $11.61M | 82.12M | 88.69M | $10.09M |
| Stock-based compensation | — | — | 0 | -5.92M | $2.30M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· This company uses different currencies across periods or line items (e.g. USD convenience translations in annual reports). Each column header shows its currency and cells in a different currency are marked; do not compare figures across currencies. Charts use only periods in the latest period's currency.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.